Latest News about RHHBY
Recent news which mentions RHHBY
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
From Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
From InvestorPlace
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
December 13, 2022
From Benzinga
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
December 12, 2022
From Benzinga
From Benzinga
After 16 Years, Roche's Pharma Division Head Decides To Step Down
December 12, 2022
From Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
From Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
December 08, 2022
From Motley Fool
From Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
November 16, 2022
From Benzinga
Successful Alzheimer's Data Would Have Placed Roche At Two-Year Competitive Advantage
November 15, 2022
From Benzinga
Roche Inks Second Drug Discovery Deal With Jnana Therapeutics
November 15, 2022
From Benzinga
FDA Grants Conditional Approval To First Antibody Drug Conjugate From ImmunoGen For Pretreated Ovarian Cancer
November 15, 2022
From Benzinga
Why Is Cassava Sciences (SAVA) Stock Up Today?
November 14, 2022
From InvestorPlace
Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
November 14, 2022
From Benzinga
Why Is Biogen (BIIB) Stock Up Today?
November 14, 2022
From InvestorPlace
The OTCQB Venture Market Records 4 Months Of Consecutive Volume Increases In OTC Market Group's Most-Active List In October
November 14, 2022
From Benzinga
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
From Benzinga
Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In Focus
November 14, 2022
From Benzinga
Why Shares Of Eli Lilly And Biogen Are Rallying Today
November 14, 2022
From Benzinga
6 ETFs That Are All You Need for Retirement
October 30, 2022
From Motley Fool
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
From Benzinga
Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
October 27, 2022
From Benzinga
From Benzinga
Roche Posts Lower Quarterly Sales As Demand For COVID Products Slide
October 18, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.